Skip to content

Effects of symbiotics on diarrhea after gastrectomy: an interventional study

Effects of symbiotics on diarrhea after gastrectomy: an interventional study - Effects of symbiotics on diarrhea after gastrectomy: an interventional study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050892
Enrollment
10
Registered
2023-06-15
Start date
2023-06-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Administration of Super Symbiotic LBG-P (3.0 g/day of live lactic acid bacteria and bifidobacteria, 20.4 g/day of oligosaccharides) for 28 days

Sponsors

Kyoto University Hospital Department of Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)20 to 85 years of age (2)Histologically diagnosed as gastric cancer (3)Gastrectomy (excluding partial gastrectomy) with R0 resection (4)Pathological Stage I, II, or III (5)More than 6 months have passed since surgery (6)No recurrence (7)Performance status less than 2 (8)Organ function (laboratory tests): satisfy all of the following (i) White blood cell count: more than 2,000/mm3 (ii) Hemoglobin: more than 8.0 g/dL (iii) Platelet count: more than 50000/ mm3 (iv) Total bilirubin: less than 3 mg/dL (v) AST: less than 100 U/L (vi) ALT: less than 100 U/L (vii) Serum creatinine: less than 2.0 mg/dL (9) Consent for participation in the study has been obtained from the subject.

Exclusion criteria

Exclusion criteria: (1)GSRS diarrhea symptom subscale score of 3 or less (2)Patients with the following history or treatment: esophagectomy, gastrointestinal bypass, massive small bowel resection, pancreaticoduodenectomy, prior chemotherapy within 6 months, prior radiation therapy within 6 months (3)Patients with the following comorbidities: inflammatory bowel disease, colostomy, liver cirrhosis, renal failure requiring dialysis (4)Patients under the following treatment: laxatives, antibiotics (5)Patients with milk allergy (6)Foreigners (7) Patients who have expressed their refusal to participate in the study (8)Other patients whom the physician deems inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Difference in GSRS diarrhea symptom subscale scores before and after treatment

Countries

Japan

Contacts

Public ContactYusuke Fujita

Kyoto University Hospital Department of Surgery

yusuke0424@kuhp.kyoto-u.ac.jp075-366-7595

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026